Trastuzumab deruxtecan (solution)
| Catalog Number | Pack Size | List Price* | Quantity | |
|---|---|---|---|---|
| HY-138298-1MG | 1 mg (10 mg/mL * 100 μL in Aqueous solution) | 1'128,00 | Add | |
| HY-138298-5MG | 5 mg (10 mg/mL * 500 μL in Aqueous solution) | 2'547,00 | Add |
* CHF, excl. 8.1% VAT and shipping costs
Product Description
Best price guarantee – we offer you the lowest price in Switzerland. Please contact us for a quote if needed.
Trastuzumab deruxtecan (T-DXd; DS-8201a) (solution) is an anti-human epidermal growth factor receptor 2 (HER2) antibody-drug conjugate (ADC). Trastuzumab deruxtecan is composed of a humanized anti-HER2 antibody, an enzymatically cleavable peptide-linker, a topoisomerase I inhibitor (a toxin component of Dxd). Trastuzumab deruxtecan can be used for the research of HER2-positive breast cancer and gastric cancer[1][2].
| Category | Antibody |
| Supplier | MedChem Express |
| Regulatory Status | RUO |
| Research Field | Cancer, Antibody-drug Conjugate/ADC Related,JAK/STAT Signaling,Protein Tyrosine Kinase/RTK |
| Format | Solubility: H2O |
| Grade | Clinical information: Launched |
| Purity | 99.4% |
| CAS-Number | 1826843-81-5 |
| Storage Conditions | -80°C, protect from light |
| Disclaimer | Shipped on dry ice - extra freight charge will occur |
| Product Line | Biosimilar |
| Tech. Data Sheet | View datasheet |
| Link To Supplier | http://www.medchemexpress.com |
| Shipping Details | Dry Ice |
| Material Safety Data Sheet | Download PDF |
